Mutant p53 exerts oncogenic functions and promotes epithelial-mesenchymaltransition (EMT) in endometrial cancer (EC) by directly binding to the promoter ofmiR-130b, a negative regulator of zinc finger E-box-binding homeobox 1 (ZEB-1), andinhibiting its transcription. The gene discussed is ZEB1; the disease is endometrial cancer.